Your search for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Number of alerts found: 38

2024/0900 - EMTRICITABINA + RILPIVIRINA + TENOFOVIR ALAFENAMIDA [200 + 25 + 25 MG; COMP]

EMTRICITABINA + RILPIVIRINA + TENOFOVIR ALAFENAMIDA [200 + 25 + 25 MG; COMP] EMTRICITABINA + RILPIVIRINA + TENOFOVIR ALAFENAMIDA [200 + 25 + 25 MG; COMP]

CPV: 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Place of execution:
2024/0900 - EMTRICITABINA + RILPIVIRINA + TENOFOVIR ALAFENAMIDA [200 + 25 + 25 MG; COMP]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000278
Publication:
June 18, 2025, 6:34 a.m.
2024/0900-DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP] (D559)

DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP] Medicamentos do foro oncológico e imunomoduladores

CPV: 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Place of execution:
2024/0900-DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP] (D559)
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000166
Publication:
June 18, 2025, 6:32 a.m.
2024/0900-DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] (D542)

DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] Medicamentos antirretrovíricos para o tratamento da infeção por VIH

CPV: 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Place of execution:
2024/0900-DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] (D542)
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000166
Publication:
June 12, 2025, 2:46 p.m.
Dostawy leków dla NZOZ Łużyckie Centrum Medyczne w Lubaniu sp. z o.o. – Część 2

Przedmiotem zamówienia są: a.dostawy leków dla NZOZ Łużyckie Centrum Medyczne w Lubaniu sp. z o.o. stosownie do Części Nr 1, Nr 2, Nr 3, Nr 4, Nr 5, Nr 6, Nr 7, Nr 8, Nr 9,Nr 10, Nr 11, Nr 13, Nr 14, Nr 15, Nr 16, Nr 17 i …

CPV: 33100000 Medical equipments, 33124100 Diagnostic devices, 33600000 Pharmaceutical products, 33610000 Medicinal products for the alimentary tract and metabolism, 33615100 Insulin, 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system, 33640000 Medicinal products for the genitourinary system and hormones, 33690000 Various medicinal products, 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, 33651100 Antibacterials for systemic use, 33651500 Immune sera and immunoglobulins, 33660000 Medicinal products for the nervous system and sensory organs, 33661100 Anaesthetics, 33692200 Parenteral nutrition products, 33692510 Intravenous fluids
Deadline:
July 11, 2025, 9 a.m.
Deadline type:
Submitting a bid
Place of execution:
Dostawy leków dla NZOZ Łużyckie Centrum Medyczne w Lubaniu sp. z o.o. – Część 2
Awarding body:
Niepubliczny Zakład Opieki Zdrowotnej Łużyckie Centrum Medyczne w Lubaniu spółka z ograniczoną odpowiedzialnością
Award number:
ZP/08/2025
Publication:
June 12, 2025, 2:27 p.m.
Dostawa leku z Programu Lekowego - Tisagenlecleucel

Dostawa leku z Programu Lekowego - Tisagenlecleucel - 1 ZADANIE Dostawa leku z Programu Lekowego - Tisagenlecleucel - 1 zadanie

CPV: 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Deadline:
July 11, 2025, noon
Deadline type:
Submitting a bid
Place of execution:
Dostawa leku z Programu Lekowego - Tisagenlecleucel
Awarding body:
UNIWERSYTECKI SZPITAL KLINICZNY IM JANA MIKULICZA - RADECKIEGO WE WROCŁAWIU
Award number:
DZP.242.193.2025
Publication:
June 12, 2025, 1:58 p.m.
2023/0492 - CEFTAZIDIMA + AVIBACTAM [2000 MG + 500 MG; PÓ CONC SOL INJ; F/AMP]

CEFTAZIDIMA + AVIBACTAM [2000 MG + 500 MG; PÓ CONC SOL INJ; F/AMP] CEFTAZIDIMA + AVIBACTAM [2000 MG + 500 MG; PÓ CONC SOL INJ; F/AMP]

CPV: 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Place of execution:
2023/0492 - CEFTAZIDIMA + AVIBACTAM [2000 MG + 500 MG; PÓ CONC SOL INJ; F/AMP]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000314
Publication:
June 12, 2025, 1:12 p.m.
2023/0492 - CEFTAZIDIMA + AVIBACTAM [2000 MG + 500 MG; PÓ CONC SOL INJ; F/AMP]

CEFTAZIDIMA + AVIBACTAM [2000 MG + 500 MG; PÓ CONC SOL INJ; F/AMP] CEFTAZIDIMA + AVIBACTAM [2000 MG + 500 MG; PÓ CONC SOL INJ; F/AMP]

CPV: 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, 33692200 Parenteral nutrition products
Place of execution:
2023/0492 - CEFTAZIDIMA + AVIBACTAM [2000 MG + 500 MG; PÓ CONC SOL INJ; F/AMP]
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000166
Publication:
June 12, 2025, 12:45 p.m.
2024/0900-DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] (D542)

DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] Medicamentos antirretrovíricos para o tratamento da infeção por VIH

CPV: 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Place of execution:
2024/0900-DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] (D542)
Awarding body:
Unidade Local de Saúde Santa Maria, E.P.E.
Award number:
251000314
Publication:
June 12, 2025, 12:26 p.m.
Raamovereenkomst voor de levering van pomalidomide

Raamovereenkomst voor de levering van pomalidomide Levering van pomalidomide aan de leden in Zuid-Limburg Pomalidomide voor ziekenhuizen gelegen in Noord-Limburg

CPV: 33600000 Pharmaceutical products, 33690000 Various medicinal products, 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, 33652000 Antineoplastic and immunomodulating agents
Deadline:
July 8, 2025, 11:45 a.m.
Deadline type:
Submitting a bid
Place of execution:
Raamovereenkomst voor de levering van pomalidomide
Awarding body:
Hospilim VZW
Award number:
2025-HospiLim-101
Publication:
June 11, 2025, 8:33 a.m.
Arzneispezialität Opdualag

Lieferung der Arzneimittelspezialität Opdualag Lieferung der Arzneimittelspezialität Opdualag 240mg / 80 mg Konzentrat zur Herstellung einer Infusionslösung

CPV: 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, 33652000 Antineoplastic and immunomodulating agents
Place of execution:
Arzneispezialität Opdualag
Awarding body:
Wiener Gesundheitsverbund – Vorstandsressort Einkauf (GED EKF)
Award number:
GED-A/70/2024/EKF
Publication:
June 6, 2025, 11:53 a.m.